ArticleBreast cancer research : BCR2006

Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.

Fabrice Journe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.